↓ Skip to main content

Dove Medical Press

Role of everolimus in the treatment of renal cell carcinoma

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2009
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
25 Mendeley
Title
Role of everolimus in the treatment of renal cell carcinoma
Published in
Therapeutics and Clinical Risk Management, August 2009
DOI 10.2147/tcrm.s4895
Pubmed ID
Authors

Saby George, Ronald M Bukowski

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 24%
Student > Ph. D. Student 6 24%
Student > Doctoral Student 4 16%
Researcher 4 16%
Professor 1 4%
Other 1 4%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 12 48%
Agricultural and Biological Sciences 4 16%
Biochemistry, Genetics and Molecular Biology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Chemistry 1 4%
Other 1 4%
Unknown 4 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2016.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#41,920
of 122,459 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 17 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,459 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.